Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nkarta, Inc. | 390,023 | reported | 15 Jan 2026 | tx 34+3,530,900−276,076 |
| OncoMed Pharmaceuticals Inc | 77,534 | reported | 10 Oct 2017 | tx 40+1,149,171−203,231 |
| enGene Holdings Inc. | 22,500 | reported | 16 Jun 2025 | tx 2+62,500 |
| VIACELL INC | 15,000 | reported | 30 May 2007 | tx 2+30,000 |
| Pacira BioSciences, Inc. | 12,724 | reported | 13 Jun 2024 | tx 66+158,906−66,381 |
| Protara Therapeutics, Inc. | 12,700 | reported | 08 Jun 2018 | tx 3+32,699 |
| Relypsa Inc | 0 | reported | 01 Sept 2016 | tx 15+20,040−57,795 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jan 2026 | SALE | Nkarta, Inc. | 26,046 | 2.07 USD | |
| 06 Jan 2026 | GRANT_AWARD | Nkarta, Inc. | 94,000 | 0.00 USD | |
| 06 Jan 2026 | GRANT_AWARD | Nkarta, Inc. | 562,000 | 0.00 USD | deriv |
| 18 Jun 2025 | SALE | Nkarta, Inc. | 1,790 | 1.79 USD | |
| 16 Jun 2025 | GRANT_AWARD | enGene Holdings Inc. | 22,500 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Nkarta, Inc. | 377,000 | 0.00 USD | deriv |
| 15 Jan 2025 | SALE | Nkarta, Inc. | 17,378 | 2.20 USD | |
| 03 Jan 2025 | GRANT_AWARD | Nkarta, Inc. | 94,500 | 0.00 USD | |
| 03 Jan 2025 | GRANT_AWARD | Nkarta, Inc. | 565,500 | 0.00 USD | deriv |
| 18 Jun 2024 | SALE | Nkarta, Inc. | 1,770 | 5.60 USD | |
| 15 Jun 2024 | GRANT_AWARD | enGene Holdings Inc. | 40,000 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | Pacira BioSciences, Inc. | 5,230 | 0.00 USD | |
| 13 Jun 2024 | SALE | Pacira BioSciences, Inc. | 880 | 28.38 USD | |
| 12 Jun 2024 | GRANT_AWARD | Pacira BioSciences, Inc. | 12,179 | 0.00 USD | deriv |
| 04 Mar 2024 | OTHER | Nkarta, Inc. | 137,642 | 13.33 USD | |
| 01 Mar 2024 | OTHER | Nkarta, Inc. | 12,358 | 13.00 USD | |
| 16 Jan 2024 | SALE | Nkarta, Inc. | 9,697 | 8.74 USD | |
| 04 Jan 2024 | GRANT_AWARD | Nkarta, Inc. | 85,000 | 0.00 USD | |
| 04 Jan 2024 | GRANT_AWARD | Nkarta, Inc. | 509,500 | 0.00 USD | deriv |
| 20 Jun 2023 | SALE | Nkarta, Inc. | 1,704 | 4.85 USD | |
| 14 Jun 2023 | GRANT_AWARD | Pacira BioSciences, Inc. | 1,775 | 0.00 USD | |
| 14 Jun 2023 | GRANT_AWARD | Pacira BioSciences, Inc. | 12,925 | 0.00 USD | deriv |
| 05 Jun 2023 | SALE | Pacira BioSciences, Inc. | 580 | 38.34 USD | |
| 15 May 2023 | EXERCISE | Pacira BioSciences, Inc. | 7,000 | 29.90 USD | |
| 15 May 2023 | SALE | Pacira BioSciences, Inc. | 7,000 | 41.85 USD |